N-acetyl-L-leucine: a promising treatment option for traumatic brain injury  

作　　者：Chinmoy Sarkar Marta M.Lipinski 

机构地区：[1]Shock,Trauma and Anesthesiology Research(STAR)Center,Department of Anesthesiology,University of Maryland School of Medicine,Baltimore,MD,USA [2]Department of Anatomy and Neurobiology,University of Maryland School of Medicine,Baltimore,MD,USA

出　　处：《Neural Regeneration Research》2022年第9期1957-1958,共2页中国神经再生研究（英文版）

基　　金：supported by IntraBio and NIH funding(R01NS091218 and R01NS091218)to MML.

摘　　要：Traumatic brain injury(TBI)is a mechanical injury to the brain,which can be sustained due to falls,accidents,contact sports or in combat situation.It is a serious health problem-affecting people of all ages worldwide.As per the recent epidemiological study,more than 55 million people suffer from TBI annually(GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators,2019),and its prevalence has increased by almost 8.4%between 1990 and 2016(GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators,2019).Depending on severity,TBI can lead to premature death and disability.

关 键 词：SUSTAINED TRAUMATIC injury 

分 类 号：R651.15[医药卫生—外科学]